Home > Journals > Journal of Neurosurgical Sciences > Past Issues > Journal of Neurosurgical Sciences 2012 September;56(3) > Journal of Neurosurgical Sciences 2012 September;56(3):203-7

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

  CUTTING EDGE NEUROSURGERY 

Journal of Neurosurgical Sciences 2012 September;56(3):203-7

Copyright © 2012 EDIZIONI MINERVA MEDICA

language: English

Current use of biologic graft extenders for spinal fusion

Coseo N. M. 1, Saldua N. 1, Harrop J. 2

1 Naval Medical Center San Diego, San Diego, CA, USA; 2 Thomas Jefferson Medical College, Philadelphia, PA, USA


PDF


Use of biologic graft extenders in spinal fusions is increasing. Multiple allograft alternatives exist to the “gold-standard” autologous bone grafting. The ideal graft extender is osteoconductive, osteoinductive and has osteogenic potential. While the ideal graft extender has yet to be found, available bone graft extenders have varying degrees of predominately osteoconductive and osteoinductive properties. This review will provide an update on available graft extenders including bone morphogenetic proteins, mesenchymal stem cells, and demineralized bone matrix. The goal is to provide a review of the current use in spinal fusions and future directions in biologics for spinal fusion.

top of page